-
2024-516078-31-00
10
2015-05-05
Recurrent and Primary Refractory Ewing Sarcoma
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2023-506146-23-00
4
2025-11-17
Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the Bladder
-
2024-520108-25-00
4
2025-11-05
Non-small cell lung cancer (NSCLC)
-
2024-516909-23-00
4
2025-10-28
Locally Advanced Resectable Gastroesophageal Adenocarcinoma
-
2025-520809-12-00
10
2025-10-16
Diabetic Macular Edema
-
2024-512914-16-00
5
2025-09-12
Relapsing-remitting Multiple Sclerosis
-
2024-516473-72-00
5
2025-07-31
Multifocal Motor Neuropathy
-
2024-519773-19-00
5
2025-07-31
Gastroesophageal Junction Adenocarcinoma
-
2024-515523-11-00
5
2025-06-09
Chronic Weight Management
-
2024-514081-40-00
5
2025-06-06
Obesity, Overweight
-
2024-515524-36-00
5
2025-05-30
Chronic Weight Management
-
2024-511754-41-00
4
2025-05-29
idiopathic pulmonary fibrosis
-
2024-513282-39-00
5
2025-05-28
Hidradenitis Suppurativa (HS)
-
2024-516814-39-00
5
2025-05-20
Chronic rhinosinusitis with nasal polyps
-
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
-
2024-518207-22-00
4
2025-05-15
Hereditary Angioedema
-
2024-512180-31-00
4
2025-03-14
Oligometastatic renal cell carcinoma
-
2024-512946-41-00
5
2025-03-05
Menstrual Migraine
-
2024-515022-88-00
5
2025-03-03
Dry Age-Related Macular Degeneration (AMD) with geographic atrophy (GA
-
2024-513970-23-00
4
2025-02-27
Previously Untreated Chronic Lymphocytic Leukemia
-
2023-508055-40-00
6
2025-02-18
Obesity
-
2024-518343-38-00
5
2025-02-12
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2024-518964-11-01
4
2025-01-27
Metastatic medulloblastoma and other embryonal tumours